v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Total revenue $ 2,379 $ 4,298 $ 20,733 $ 15,348
Operating expenses:        
Research and development 22,881 19,622 65,328 70,667
General and administrative 9,027 7,547 26,178 19,606
Total operating expenses 31,908 27,169 91,506 90,273
Loss from operations 29,529 22,871 70,773 74,925
Interest and other income, net 175 167 308 925
Interest and other expense, net (1,033) (521) (2,301) (1,229)
Loss on extinguishment of debt 0 0 0 (1,237)
Loss before provision for income taxes 30,387 23,225 72,766 76,466
Provision for income taxes 0 0 0 5
Net loss 30,387 23,225 72,766 76,471
Net loss attributable to common shareholders $ 30,387 $ 23,225 $ 72,766 $ 76,471
Net loss per share attributable to common shareholders:        
Basic and diluted $ 0.54 $ 0.47 $ 1.32 $ 1.63
Weighted average number of shares used in net loss per share calculations:        
Basic and diluted 56,174,644 49,026,499 54,958,365 46,808,437
Research And Development Revenue | Other        
Total revenue $ 2,379 $ 2,732 $ 7,597 $ 7,176
Research And Development Revenue | Related Party        
Total revenue 0 1,566 13,136 4,962
Grant        
Total revenue $ 0 $ 0 $ 0 $ 3,210

Source